Drugs / BIBW 2948
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00423137 | Jan 2007 → Jul 2008 | chronic bronchitis | Boehringer Ingelheim | Completed | Missed primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIBW 2948 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00423137 ↗ |
| Known as | BIBW 2948 BS | “Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease.” PMID 20007923 ↗ Dec 2009 |
| Action | Inhibit | “Inhaled BIBW 2948 induced a dose-related inhibition of EGFR internalization” PMID 20007923 ↗ Dec 2009 |
| Route | Inhaled | “Inhaled BIBW 2948” PMID 20007923 ↗ Dec 2009 |
| Target | EGFR | “inhaled EGFR antagonist (BIBW 2948)” PMID 20007923 ↗ Dec 2009 |